Tags

Type your tag names separated by a space and hit enter

Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement.
Med J Aust. 2006 Sep 04; 185(5):268-72.MJ

Abstract

Vitamin D deficiency has re-emerged as a significant paediatric health issue, with complications including hypocalcaemic seizures, rickets, limb pain and fracture. A major risk factor for infants is maternal vitamin D deficiency. For older infants and children, risk factors include dark skin colour, cultural practices, prolonged breastfeeding, restricted sun exposure and certain medical conditions. To prevent vitamin D deficiency in infants, pregnant women, especially those who are dark-skinned or veiled, should be screened and treated for vitamin D deficiency, and breastfed infants of dark-skinned or veiled women should be supplemented with vitamin D for the first 12 months of life. Regular sunlight exposure can prevent vitamin D deficiency, but the safe exposure time for children is unknown. To prevent vitamin D deficiency, at-risk children should receive 400 IU vitamin D daily; if compliance is poor, an annual dose of 150,000 IU may be considered. Treatment of vitamin D deficiency involves giving ergocalciferol or cholecalciferol for 3 months (1000 IU/day if < 1 month of age; 3000 IU/day if 1-12 months of age; 5000 IU/day if > 12 months of age). High-dose bolus therapy (300,000-500,000 IU) should be considered for children over 12 months of age if compliance or absorption issues are suspected.

Authors+Show Affiliations

The Children's Hospital at Westmead, Sydney, NSW, Australia. craigm2@chw.edu.auNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Consensus Development Conference
Journal Article
Practice Guideline

Language

eng

PubMed ID

16948623

Citation

Munns, Craig, et al. "Prevention and Treatment of Infant and Childhood Vitamin D Deficiency in Australia and New Zealand: a Consensus Statement." The Medical Journal of Australia, vol. 185, no. 5, 2006, pp. 268-72.
Munns C, Zacharin MR, Rodda CP, et al. Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. Med J Aust. 2006;185(5):268-72.
Munns, C., Zacharin, M. R., Rodda, C. P., Batch, J. A., Morley, R., Cranswick, N. E., Craig, M. E., Cutfield, W. S., Hofman, P. L., Taylor, B. J., Grover, S. R., Pasco, J. A., Burgner, D., & Cowell, C. T. (2006). Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. The Medical Journal of Australia, 185(5), 268-72.
Munns C, et al. Prevention and Treatment of Infant and Childhood Vitamin D Deficiency in Australia and New Zealand: a Consensus Statement. Med J Aust. 2006 Sep 4;185(5):268-72. PubMed PMID: 16948623.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. AU - Munns,Craig, AU - Zacharin,Margaret R, AU - Rodda,Christine P, AU - Batch,Jennifer A, AU - Morley,Ruth, AU - Cranswick,Noel E, AU - Craig,Maria E, AU - Cutfield,Wayne S, AU - Hofman,Paul L, AU - Taylor,Barry J, AU - Grover,Sonia R, AU - Pasco,Julie A, AU - Burgner,David, AU - Cowell,Christopher T, AU - ,, AU - ,, PY - 2006/02/13/received PY - 2006/07/19/accepted PY - 2006/9/5/pubmed PY - 2006/9/29/medline PY - 2006/9/5/entrez SP - 268 EP - 72 JF - The Medical journal of Australia JO - Med. J. Aust. VL - 185 IS - 5 N2 - Vitamin D deficiency has re-emerged as a significant paediatric health issue, with complications including hypocalcaemic seizures, rickets, limb pain and fracture. A major risk factor for infants is maternal vitamin D deficiency. For older infants and children, risk factors include dark skin colour, cultural practices, prolonged breastfeeding, restricted sun exposure and certain medical conditions. To prevent vitamin D deficiency in infants, pregnant women, especially those who are dark-skinned or veiled, should be screened and treated for vitamin D deficiency, and breastfed infants of dark-skinned or veiled women should be supplemented with vitamin D for the first 12 months of life. Regular sunlight exposure can prevent vitamin D deficiency, but the safe exposure time for children is unknown. To prevent vitamin D deficiency, at-risk children should receive 400 IU vitamin D daily; if compliance is poor, an annual dose of 150,000 IU may be considered. Treatment of vitamin D deficiency involves giving ergocalciferol or cholecalciferol for 3 months (1000 IU/day if < 1 month of age; 3000 IU/day if 1-12 months of age; 5000 IU/day if > 12 months of age). High-dose bolus therapy (300,000-500,000 IU) should be considered for children over 12 months of age if compliance or absorption issues are suspected. SN - 0025-729X UR - https://www.unboundmedicine.com/medline/citation/16948623/Prevention_and_treatment_of_infant_and_childhood_vitamin_D_deficiency_in_Australia_and_New_Zealand:_a_consensus_statement_ L2 - https://www.mja.com.au/public/issues/185_05_040906/mun10153_fm.html DB - PRIME DP - Unbound Medicine ER -